Results 141 to 150 of about 23,087 (229)

Breaking the Debilitating Cycle: Pathophysiology, Assessment, and Multimodal Intervention of Secondary Debilitation After Hip Fracture in Older Adults—A Narrative Review

Orthopaedic Surgery, Volume 18, Issue 9, Page 1785-1803, September 2026.
This article provides a comprehensive overview of the pathophysiological mechanisms underlying “secondary debilitation after hip fracture,” discusses the clinical application of risk assessment tools, and presents a phased, stepwise intervention strategy aimed at interrupting the “vicious cycle.” ABSTRACT Hip fractures pose a serious threat to the ...
Wenyang Xu, Fan Xu, Maoqiang Fan, Yao Liu, Zhe Song   +4 more
wiley   +1 more source

Patterns of Osteoporosis Treatment Initiation Following Low‐Trauma Fracture: A Population‐Based Retrospective Cohort Study in New South Wales, Australia, Using Linked Administrative Health Data

Medical Journal of Australia, Volume 224, Issue 9, September 2026.
ABSTRACT Objectives To characterise osteoporosis medicine prescribing patterns following low‐trauma fractures and identify predictors of early treatment initiation. Study Type Retrospective population‐based cohort study. Setting New South Wales, Australia, using statewide linked administrative health data.
Mike Lin, Huy Nguyen, Thach Tran, Robert D. Blank, Dana Bliuc, Jacqueline R. Center   +5 more
wiley   +1 more source

Denosumab Treatment of Severe Disuse Osteoporosis in a Boy With Spinal Muscular Atrophy

Acta Medica Iranica, 2017
Denosumab is a fully human recombinant monoclonal antibody to the receptor activator of nuclear factor-κB ligand. Denosumab is used in the treatment of postmenopausal osteoporosis and cancer-related bone disorders.
Stepan Kutilek
doaj  

Significant improvement of bone mineral density by denosumab treatment in Japanese osteoporotic patients following breast cancer treatment

, 2018
Yukio Nakamura,1,2 Mikio Kamimura,3 Akio Morikawa,4 Akira Taguchi,5 Takako Suzuki,1 Hiroyuki Kato1 1Department of Orthopaedic Surgery, Shinshu University School of Medicine, Matsumoto, 2Department of Orthopedic Surgery, Showa-Inan General Hospital ...
Kamimura M, Kato H, Suzuki T, Morikawa A, Nakamura Y, Taguchi A   +5 more
core  

Case Report: Reopening the anabolic window - romosozumab added to ongoing denosumab for severe osteoporosis in two kidney transplant recipients. [PDF]

Front Endocrinol (Lausanne)
Barbuto S, Mastromauro P, Zavatta G, Vetrano D, Mistretta A, Bisceglia N, Comai G, Pagotto U, La Manna G, Cianciolo G.   +9 more
europepmc   +1 more source

Medication-related osteonecrosis of the external auditory canal and treatment with teriparatide. [PDF]

JCEM Case Rep
Xia D, Ting MJM, Atlas MD, Boeddinghaus R, Stuckey BGA.   +4 more
europepmc   +1 more source

Osteoporosis treatment with biosimilars in Malaysia and Thailand: a budget impact analysis. [PDF]

Arch Osteoporos
Siachalinga L, Jones A, Kim K, Downes M, Solev I, Lee K, Valleenukul T, Kim H.   +7 more
europepmc   +1 more source

Role of Denosumab in Chronic Kidney Disease with Paget's Disease of Bone: A Case Report and Review of Literature. [PDF]

J Orthop Case Rep
Totaganti M, Suryadevara V, Raju S, Sahoo J, Naik D, Kamalanathan S.   +5 more
europepmc   +1 more source

Potent bisphosphonate therapy for preventing fractures after denosumab discontinuation in osteoporosis: A GRADE-assessed systematic review and meta-analysis. [PDF]

Medicine (Baltimore)
Shah A, Khan S, Rizvi SVZ, Farhan K, Uddin M, Rizvi SUA, Fatima S, Karan AR, Khalid AA, Ali A, Ahmed S.   +10 more
europepmc   +1 more source

Correction: Management of Adverse Skeletal Effects Following Bariatric Surgery Procedures in People Living with Obesity. [PDF]

Curr Osteoporos Rep
Karam L, Paccou J.
europepmc   +1 more source